PRETREATMENT WITH HIGH DOSE CLOPIDOGREL FOR REDUCTION OF THROMBOTIC EVENTS AFTER ELECTIVE CORONARY TERRITORY STENTING WITH DRUG ELUTING STENTS: ThePROTECTED Study - The PROTECTED Study
- Conditions
- PERCUTANEOUS CORONARY INTERVENTION( USING DRUG ELUTING STENTS)
- Registration Number
- EUCTR2004-000517-19-GB
- Lead Sponsor
- Blackpool Fylde & Wyre Healthcare NHS Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 100
Consecutive patients suitable for elective coronary stenting using Drug eluting stents will be eligible and recruited for the study
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion criteria will be history of bleeding diathesis, acute myocardial infarction or acute coronary syndrome/troponin elevation within 14 days, stroke within 3 months, drug or alcohol abuse, pro-thrombin time >1.5 times control, platelet count <100,000/cu.mm, hematocrit <25%, serum creatinine > 4.0mg/dl, or previous use of theinopyridines or GP IIb/IIIa inhibitors
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method